Attachment J9 - Sample Client Letter.pdf

PDF 72 KB Posted

Attached to
Roof replacement, Building 15 and 53 A, B, C, D & Mech room in Jefferson, Arkansas
Solicitation number
75F40121R00014
Issued by

About this file

This document contains a sample client authorization letter and information about a federal contract opportunity for roof replacement services. The letter is a template for an entity responding to Solicitation Number 75F40121R00014 to obtain roof replacements at buildings 15, 53A, B, C, D and the mechanical room at the U.S. Food and Drug Administration facility in Jefferson, Arkansas. The letter requests that clients complete a past performance evaluation questionnaire and send it directly to the FDA contract specialist, Suzanne Martella, by June 5, 2021 to be considered in the source selection process which emphasizes past performance. The federal contract opportunity involves solicitation for roof repair services at the National Center for Toxicological Research buildings in Jefferson, Arkansas issued by the Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services.

View the file

Other files

Show all 17

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

75F40121R00014 ATTACHMENT J8

SAMPLE CLIENT AUTHORIZATION LETTER

(Transfer to Compan y Letter he ad)

Dear Client, We are currently responding to Solicitation Number 75F40121R00014 for Building 15, 53A, B, C, D and Mech Room Roof Replacement at the U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR), 3900 NCTR Road, Jefferson, Arkansas 72079.

The FDA has placed emphasis on past performance as a key source selection factor and requires that clients of entities responding to the solicitations be identified and their participation in the evaluation process be requested; therefore, enclosed is a (present and) Past Performance Evaluation Questionnaire (PPEQ) for your completion. We are requesting that you complete the questionnaire and send it directly to the Food and Drug Administration (FDA) no later than 12:00 pm central time on June 5, 2021 to Suzanne Martella, Contract Specialist at suzanne.martella@fda.hhs.gov .

If you have questions or require assistance regarding the attached questionnaire, please contact Suzanne Martella, FDA Contract Specialist, at 870-543-7540 or at suzanne.martella@fda.hhs.gov

Thank you for your consideration and prompt response regarding this matter.

Sincerely, {Offering Entity} mailto:suzanne.martella@fda.hhs.gov mailto:suzanne.martella@fda.hhs.gov

File details come from the government source that posted it. Updated .